Hepatitis C and its impact on renal transplantation

Related Experiment Video

Updated: Apr 17, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

8.6K

Jose M Morales1, Fabrizio Fabrizi2

  • 1Research Institute, Immunology Department, Hospital 12 de Octubre, Avenida de Cordoba s/n, 28401, Madrid, Spain.

Nature Reviews. Nephrology
|February 4, 2015
PubMed

Insights

Hepatitis C virus (HCV) infection complicates renal transplantation, impacting graft survival. Novel interferon-free therapies offer improved outcomes for patients with chronic liver disease and end-stage renal disease.

Area of Science:

  • Nephrology
  • Hepatology
  • Immunology

Background:

  • Hepatitis C virus (HCV) infection is a primary cause of chronic liver disease post-renal transplantation.
  • Dialysis is a common route for HCV acquisition in patients awaiting transplantation.
  • HCV infection negatively affects kidney graft acceptance and patient survival.

Purpose of the Study:

  • To review the complex relationship between renal transplantation, HCV infection, and liver disease.
  • To highlight advancements in treating HCV in renal transplant recipients.
  • To analyze clinical outcomes and donor-related factors in HCV-positive kidney transplantation.

Main Methods:

  • Literature review focusing on HCV infection in renal transplant recipients.
  • Analysis of current and emerging therapeutic strategies for HCV.
  • Evaluation of clinical complications, graft, and patient survival data.
  • Assessment of outcomes for kidney transplants from HCV-positive donors.

Main Results:

  • Interferon-free therapies show promise in altering the natural history of HCV post-transplantation.
  • Direct-acting antiviral agents represent a significant therapeutic advance.
  • HCV infection is associated with increased risks of liver disease, graft dysfunction, and reduced survival.
  • Transplantation from HCV-positive donors presents unique considerations and outcomes.

Conclusions:

  • Effective management of HCV is crucial for improving outcomes in renal transplant recipients.
  • Novel antiviral therapies are transforming HCV treatment paradigms in this population.
  • Careful patient selection and management are essential when considering kidney allografts from HCV-positive donors.

More Related Videos

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

1.0K
Mouse Kidney Transplantation: Models of Allograft Rejection16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

22.0K

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
782
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
872
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
63
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
603
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
364
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
266